Microcytic Anemias Flashcards

1
Q

How does anemia present? How do we test for it? How are the anemias classified?

A
  • anemia presents as hypoxia; weakness, fatigue, dyspnea, pale conjunctiva, headache, light-headedness (can present as angina/claudication in patients with CAD and atherosclerosis)
  • tested for with Hb, hematocrit, and RBC count
  • anemia is a Hb less than 13.5 g/dL in males (less than 12.5 in females)
  • classified based on mean corpuscular volume (MCV): microcytic is less than 80, normocytic is between 80 and 100, macrocytic is greater than 100
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What general principle is involved in the case of microcytic anemia? What are the four types?

A
  • microcytic anemia is due to a decreased production of Hb; erythroblasts essentially undergo an extra division (hence the smaller size) in order to attempt to maintain the Hb concentration of each RBC
  • a decrease in any component of Hb can cause this: heme (iron and protoporphyrin) and globin
  • iron deficiency anemia (low iron); MC
  • anemia of chronic disease (low iron)
  • sideroblastic anemia (low protoporphyrin)
  • thalassemia (low globin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is iron normally acquired by the body? How is it transferred and where is it stored? How is iron excreted/regulated?

A
  • iron is obtained in the diet; it is absorbed in the duodenum (5% is obtained in diet, 95% is recycled from already made Hb)
  • the enterocytes absorb iron and pump it into the blood via ferroportin; in the blood, iron travels bound to transferrin and heads to liver hepatocytes and bone marrow macrophages where it is stored as ferritin (the macrophages eventually give the iron to the developing erythroblasts, which have transferrin receptors)
  • iron is essentially unable to be excreted! therefore, regulation occurs at the level of the enterocyte and whether or not the cell will pump the iron into the blood via ferroportin (regulated by hepcidin: decreases ferroportin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What four lab measurements are used to determine a patient’s iron status?

A
  • serum iron: the amount of iron in the blood (this iron will be bound to transferrin); (N is 100 micrograms/dL)
  • TIBC: total iron binding capacity: the amount of transferrin in the blood; (N is 300 micrograms/dL)
  • percent saturation: the amount of transferrin bound to iron (N is 33%; 1 of every 3 transferrin molecules is bound to iron); greater than 45% indicates hemochromatosis
  • serum ferritin: the amount of iron stored in cells (N is about 100-300)
  • (note that when ferritin decreases, TIBC will increase and vice versa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the most common type of anemia overall? What are the major causes of this anemia in infants, children, adults, and the elderly? How do we treat it?

A
  • iron deficiency anemia is the most common anemia overall
  • infants: breast-feeding (low iron content) and high demand
  • children: poor diet (high demand in adolescents)
  • adults: peptic ulcer disease/GI disease, malignancy, menorrhagia, pregnancy (increased demand)
  • elderly: colon polyps/carcinoma (Western world), hookworm infection (third world)
  • others: gastric surgery (achlorhydria delays reduction of non-heme iron)
  • treat with ferrous sulfate (simply increasing dietary intake is not enough)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the four stages of iron deficiency (ie, how does the deficiency progress)?

A
  • 1) depletion of stored iron (ferritin decreases; TIBC will increase as a result)
  • 2) depletion of serum iron (serum iron and percent saturation decrease)
  • *3) NORMOCYTIC anemia develops
  • 4) microcytic anemia develops
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What clinical and lab findings are associated with iron deficiency anemia?

A
  • microcytic hypochromic anemia
  • pica (urge to chew/eat abnormal things), koilonychia, angular stomatitis/chelitis, pale conjunctiva
  • elevated RDW (RBC distribution width; the spectrum of RBC size; in iron deficiency anemia, both normocytic and microcytic anemia occur, increasing the spectrum)
  • decreased ferritin to less than 50 (and increased TIBC)
  • decreased serum iron and percent saturation
  • elevated FEP (free erythrocyte protoporphyrin; because there is no iron for it to bind to in the RBC to form heme)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What syndrome involves iron deficiency anemia? What are the features of this syndrome?

A
  • Plummer-Vinson syndrome

- iron deficiency anemia, esophageal web (dysphagia), atrophic glossitis (beefy red tongue)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the most common type of anemia in hospitalized patients? How do we treat it?

A
  • anemia of chronic disease is the most common type of anemia in hospitalized patients
  • it is associated with chronic inflammation, cancer, alcoholism, etc.
  • treat the underlying cause; can give exogenous EPO in some cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the pathophysiology of anemia of chronic disease?

A
  • in chronic disease, acute phase reactants are chronically altered: ferritin and hepcidin are elevated and transferrin is decreased
  • these all act to sequester iron from the assumed microbial pathogens; major player is hepcidin, which locks iron in its stored state as ferritin and also suppresses renal EPO prodution
  • the resulting decrease in readily available iron results in anemia of chronic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What findings are associated with anemia of chronic disease?

A
  • microcytic hypochromic anemia (initially it’s normocytic)
  • increased ferritin (and decreased TIBC)
  • decreased serum iron
  • decreased percent saturation
  • normal or increased RDW (RBC distribution width)
  • increased FEP (free erythroctye protoporphyrin because iron is sequestered and not used)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is sideroblastic anemia? What are the most common causes?

A
  • sideroblastic anemia is a microcytic anemia due to defective protoporphyrin synthesis in the erythroblast, leading to decreased Hb production
  • MC congenital cause: X-linked defect in ALA-S enzyme (catalyzes the 1st step of protoporphyrin synthesis)
  • acquired causes: alcoholism (MCC overall; damage to mitochondria, where the final steps of synthesis take place), lead poisoning (Pb denatures ALA-D and ferrochelatase), vitamin B6/pyridoxine deficiency (cofactor for ALA-S; isoniazid)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the role of ALA-S, ALA-D, and ferrochelatase in protoporphyrin synthesis?

A
  • ALA-S (aminolevulinic acid synthase) catalyzes the 1st step: converts succinyl-CoA into ALA; the RLS; major cofactor is vitamin B6/pyridoxine
  • ALA-D (ALA-dehydrogenase) catalyzes the 2nd step: converts ALA into prophobullinogen; it is denatured in lead poisoning
  • (prophobullinogen is eventually made into protoporphyrin)
  • ferrochelatase is involved in the final step and binds protoporphyrin to iron in the mitochondria to form Hb; it is denatured in lead poisoning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What findings are associated with sideroblastic anemia?

A
  • microcytic hypochromatic anemia
  • increased ferritin (iron isn’t being used to bind to protoporphyrin); decreased TIBC
  • increased serum iron
  • increased percent saturation
  • low protoporphyrin (FEP)
  • histo reveals ringed sideroblasts: iron-loaded mitochondria (because not enough protoporphyrin to form Hb) form a ring around the nucleus in these erythroblasts; seen with Prussian blue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is thalassemia? This anemia is usually due to an inherited mutation - what are carriers of this mutation protected against?

A
  • thalassemia is a microcytic anemia due to the decreased synthesis of globin chains, resulting in decreased production of Hb
  • carriers of these mutations are protected against malaria via Plasmodium falciporum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the three types of Hb produced by the body? What are the normal percentages of each? What are the two types of thalassemia and which types of Hb does each affect?

A
  • HbA (97%): alpha2, beta2
  • HbA2 (2%): alpha2, delta2
  • HbF (1%): alpha2, gamma2
  • alpha-thalassemia affects the alpha-chain production, and therefore affects all three (percentages WON’T change, as all are proportionately reduced)
  • beta-thalassemia affects the beta-chain production, and therefore only affects HbA (percentages will change)
17
Q

What genetic abnormality drives alpha-thalassemia? How many copies of this gene do we have?

A
  • alpha-thalassemia is driven by DELETIONS on chromosome 16
  • this is a very important protein, and we therefore have FOUR copies of this gene! (2 on each chromosome)
  • alpha-plus allele has 1 deletion, alpha-naught allele has 2 deletions
18
Q

What results from a deletion of a single alpha-globin gene? A deletion of two genes? Three genes? Four?

A
  • (alpha-globin chain gene is found on chromosome 16)
  • 1 deletion: asymptomatic
  • 2: mild anemia (note that the cis/heterozygous version is worse than the trans/homozygous one, and is more common in Asians)
  • 3: severe anemia develops after birth; AKA compound heterozygous or HbH disease
  • 4: lethal in utero (hydrops fetalis); Hb Barts
19
Q

What is HbH? What about Hb-Barts?

A
  • these are associated with alpha-thalassemia in the setting of 3 and 4 deletions of the gene, respectively; they are seen on electrophoresis
  • HbH is seen in alpha-thalassemia with 3 deletions; it is a tetramer of beta-chains (this is obviously non-functional, hence the severe anemia seen in these patients after birth)
  • Hb-Barts is seen in alpha-thalassemia with 4 deletions; it is a tetramer of gamma-chains (hence the lethality of this disease in utero)
  • *tetramers form when there is diminished/absent alpha chains; the over abundant beta chains bind to each other instead)
20
Q

What genetic abnormality drives beta-thalassemia?

A
  • beta-thalassemia is driven by MUTATIONS of chromosome 11
  • the resulting alleles are: beta (normal), beta-plus (partially functional), and beta-naught (non functional)
  • as a result, a spectrum of disease exists from very mild (B/B-plus) to extremely severe (B-naught/B-naught)
21
Q

What is beta-thalassemia minor? What findings do we see in this disease? What percentages of Hb result?

A
  • this is the most mild form of beta-thalassemia disease and is driven by a beta/beta-plus genotype
  • patients are largely asymptomatic
  • smear reveals microcytic hypochromatic RBCs and target cells
  • Hb electrophoresis reveals isolated elevated HbA2 (this Hb has no beta chains); HbA2 greater than 3.5% is diagnostic (normal is 2%)
  • obviously, HbA is decreased
  • A: 93% (97%)
  • A2: 5% (2%)
  • F: 2% (1%)
22
Q

What is beta-thalassemia major? What findings do we see in this disease? What percentages of Hb result?

A
  • this is the most severe form of beta-thalassemia disease and is driven by a beta-naught/beta-naught genotype
  • extremely severe anemia develops 3-6 months after birth (initially, the HbF is protective)
  • alpha-chains have a large tendency to form tetramers
  • patients have massive erythroid hyperplasia: hematopoiesis expands into the marrow of the skull (“crew cut” on imaging) and facial bones (chipmunk-like facies), extramedullary hematopoiesis occurs (hepatosplenomegaly)
  • microcytic hypochromic RBCs, target cells, nucleated RBCs (indicates extramedullary hematopoiesis), very little/no HbA, elevated HbA2 and HbF
  • A: 0% (97%)
  • A2: 10% (2%)
  • F: 90% (1%)
23
Q

How do we treat beta-thalassemia major? What is a major potential complication of treatment? Infection with what organism can put these patients into crisis?

A
  • treat with chronic transfusions
  • this increases the risk for developing secondary hemochromatosis!
  • give hyrdoxyurea (this slows the loss of protective HbF)
  • patients must avoid infection with parovirus B19, which infects erythroblasts; these patients have VERY few functioning RBCs, so any other insult (no matter how minor) can put them into crisis
24
Q

Other than hepcidin, how else is iron absorption regulated?

A
  • via HFE! HFE increases in response to high levels of iron
  • HFE binds to transferrin receptors to decrease their binding capacity for transferrin (thus, this decreases the amount of iron that is able to enter cells)
  • this is why in hemochromatosis (defective HFE gene), iron overload happens
25
Q

What does lead poisoning result in? How do we treat it?

A
  • LLEEAADD
  • Lead Lines on gingivae and long bones (look for increased density of epiphyses)
  • Encephalopathy
  • Erythroctye basophilic stippling (lead poisoning inhibits rRNA degradation, so RBCs retain rRNA aggregates that stain blue)
  • Anemia (sideroblastic because inhibition of ALA-dehydratase and ferrochelatase)
  • Abdominal colic (lead causes cramping and can be seen on x-ray)
  • wrist and foot Drops (peripheral neuropathy)
  • treat with chelators: Dimercaprol, EDTA (succimer for kids)